As Matin and Goldberg note, the accurate staging of non-small-cell lung cancer (NSCLC) is necessary to provide patients with correct information regarding prognosis and appropriate treatment recommendations. Therefore, physicians who treat
Steven M. Keller, MD
Advertisement
Articles by Steven M. Keller, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Atirmociclib/Fulvestrant Improves PFS in HR+/HER2– Breast Cancer
2
FDA Approves Companion Diagnostic for Niraparib in Advanced Ovarian Cancer
3
Which Novel Drug Classes Hold Promise in Multiple Myeloma Therapy?
4
Investigators to Discontinue Trial of Eftilagimod Alfa in Frontline NSCLC
5